Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Plaque protrusion in carotid artery stenting: what are its risks and how can we prevent them?

Courtesy of Dr. Carlos Fava.

Plaque Protrusion in Carotid Artery Stenting: What Are Its Risks and How Can We Prevent Them?Carotid artery stenting (CAS) has proven to be effective in high-risk patients. Nowadays, when performed by trained operators, its results are similar to those of surgery. This study seeks to clarify the incidence and prognosis of plaque protrusion through the stent (as observed in both control angiography and intravascular ultrasound [IVUS]) during carotid artery stenting.

 

A total of 354 carotid atherosclerotic stenoses in 328 consecutive patients who underwent stenting were retrospectively analyzed. Plaque protrusion was defined as plaque inside the stent lumen after dilatation, as observed through both digital subtraction angiography and IVUS. The incidence of ischemic stroke within 30 post-operative days and the presence of ischemic lesions as observed through diffusion-weighted nuclear magnetic resonance imaging performed within 48 post-operative hours were analyzed.

 

Plaque protrusion was observed in 9 patients (2.6%). The mean age was 73 years old (most patients were male) and 80% of patients presented carotid artery lesions. No difference was observed regarding protection system or stent type used. All patients received dual antiplatelet therapy.

 

The presence of plaque protrusion was significantly higher in patients who received open-cell stents. At 30 days, the incidence of stroke was higher in the plaque protrusion patient group (66.6% vs.1.1%; p = < 0.0001). At 48 hours, lesions were observed through diffusion-weighted imaging in more patients (8) in this group than in those who received open-cell stents and presented unstable plaque.

 

Plaque protrusion was strongly associated with peri-procedural stroke.

 

Conclusion

The incidence of plaque protrusion in carotid artery stenting was 2.6% and it was associated with a high risk of ischemic complications. These findings indicate the necessity of appropriate device selection to avoid plaque protrusion.

 

Editorial Comment

While operator expertise has lowered the rates of adverse events, current technology must be improved in order to avoid plaque protrusion, which is associated with an extremely high rate of stroke.

 

This undesired event does not only affect the patient: it alters his/her family and social relationships, and it creates high costs for health systems.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Carotid Artery Stenting. Investigation of Plaque Protrusion Incidence and Prognosis.

Reference: Masashi Kotsugi, et al. J Am Coll Cardiol Intv 2017;10:824-31.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...